Sharmilla Dissanaike, MD
Surgical Critical Care · Lubbock, TXNPI 1639286123
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $772,542 of the $843,738 with a category attached, or 91.6%. Heron Therapeutics, Inc. accounts for 99.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $556,332 and has fallen 100.0% since, to $95 in 2024. Among surgical critical care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $16,226 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$841K
- Trevena, Inc.$2K
- KCI USA, Inc.$176
- CSL Behring$147
- Avita Medical Americas, LLC$91
- AbbVie$86
- plus $476 from 14 others
What the payments were for
- Consulting fees$67,5808%
- Speaking & faculty fees$1,5000%
- Travel & lodging$1,1160%
- Food & beverage$1,0000%
- Ownership interest$772,54292%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 14 | $841,262 |
| Trevena, Inc. | 1 | $1,500 |
| KCI USA, Inc. | 3 | $176 |
| CSL Behring | 7 | $147 |
| Avita Medical Americas, LLC | 2 | $91 |
| AbbVie(2 entities) | 4 | $86 |
| Integra Lifesciences Corporation | 3 | $75 |
| Acera Surgical, Inc. | 1 | $61 |
| Kerecis Limited | 2 | $47 |
| Smith+Nephew | 3 | $45 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $41 |
| Kls-martin L.p. | 2 | $41 |
| Stryker | 1 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Lifenet Health | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| TELA Bio, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$843,738 in reported general payments places this provider in the 95th percentile of 104 surgical critical care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical critical care in Lubbock
- John GriswoldLubbock$21K
- Tabitha ThreattLubbock$5K
- Samir AwadHouston$1.6M
- Robert SouthardHouston$215K
- Rondel AlbaradoHouston$197K
- Anthony CahillWaco$43K
- Michael CorneilleSan Antonio$35K
- Christopher CouchTyler$30K
- Ryan KostkaFort Worth$30K
- Daniel BonvilleHouston$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.